Chuck Akre - Akre Capital Management
Holding/activity history for Bradley Pharmaceutical/bdy (BDY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2007 Q4 | 0 | 0.00 | Sell 100.00% | 0.28 | SEC | ||
| 2007 Q3 | 228,100 | 0.28 | $18.20 | $4,151,000 | SEC | ||
| 2007 Q2 | 228,100 | 0.31 | Reduce 47.98% | 0.29 | $21.71 | $4,952,000 | SEC |
| 2007 Q1 | 438,521 | 0.60 | Add 0.86% | <0.01 | $19.19 | $8,415,000 | SEC |
| 2006 Q4 | 434,777 | 0.68 | Add 0.16% | <0.01 | $20.58 | $8,948,000 | SEC |
| 2006 Q3 | 434,104 | 0.63 | Add 2.99% | 0.02 | $15.92 | $6,911,000 | SEC |
| 2006 Q2 | 421,504 | 0.40 | Reduce 0.28% | <0.01 | $10.20 | $4,299,000 | SEC |
| 2006 Q1 | 422,704 | 0.55 | Reduce 51.79% | 0.45 | $14.87 | $6,286,000 | SEC |
| 2005 Q4 | 876,852 | 0.86 | Add 1.39% | 0.01 | $9.50 | $8,330,000 | SEC |
| 2005 Q3 | 864,851 | 0.97 | Add 1.66% | 0.02 | $10.92 | $9,444,000 | SEC |
| 2005 Q2 | 850,705 | 0.86 | Add 2.32% | 0.02 | $10.75 | $9,145,000 | SEC |
| 2005 Q1 | 831,400 | 0.83 | Add 53.39% | 0.29 | $9.56 | $7,948,000 | SEC |
| 2004 Q4 | 542,000 | 1.23 | Add 209.71% | 0.83 | $19.40 | $10,515,000 | SEC |
| 2004 Q3 | 175,000 | 0.60 | Buy | 0.60 | $20.35 | $3,561,000 | SEC |